Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -554 | -413 | -356 | -210 | 78 |
| Depreciation Amortization | 28 | 22 | 15 | 8 | 30 |
| Accounts receivable | 133 | -9 | 153 | 588 | -328 |
| Accounts payable and accrued liabilities | 251 | 1,086 | 500 | 29 | -4 |
| Other Working Capital | 252 | 1,014 | 542 | 432 | -390 |
| Other Operating Activity | -368 | -1,055 | -646 | -617 | 348 |
| Operating Cash Flow | $-257 | $645 | $208 | $230 | $-265 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -12 | -10 | -7 | -18 |
| Other Investing Activity | -3 | -4 | -5 | -5 | 1 |
| Investing Cash Flow | $-16 | $-15 | $-14 | $-13 | $-17 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,168 | 2,168 | 2,168 | 2,168 | 2,450 |
| End Cash Position | 1,895 | 2,798 | 2,362 | 2,385 | 2,168 |
| Net Cash Flow | $-273 | $630 | $194 | $217 | $-282 |
| Free Cash Flow | |||||
| Operating Cash Flow | -257 | 645 | 208 | 230 | -265 |
| Capital Expenditure | -13 | -12 | -10 | -7 | -18 |
| Free Cash Flow | -270 | 633 | 199 | 223 | -283 |